“Me Too Drugs: R&D Innovations or Imitations? ” A short presentation followed by Q&A with speaker Dr. Joe DiMasi of Tufts University.
A “me too” drug is similar in chemical structure or has the same mechanism of action as the protype. According to the 2004 FDA report, only about one-third of the drug license application approvals over the preceding eight years were considered as ‘new’. What are the merits of these look-alikes? Is the pharmaceuticals industry providing enhanced therapeutic options or creating wasteful resources? Bring your ideas and join us to get your dose of me too analysis with speaker, Joe DiMasi, of Tufts University! Join us LIVE to have YOUR questions answered!
What You Will Learn
- Trends in the Speed of Competitive Entry in Drug Classes
- Knock-offs or Win, Place, and Show: Are Me-Toos Copycats or Losers in a Development Race?
- First-in-Class versus Me-Toos: Who Develops and Who Patents First?
- Are First-in-Class Drugs Always Best-in-Class?
- And much more…
Date: Thursday, April 14, 2011
Time: 2:00-3:00 pm ET
Meet Your Experts
Dr. DiMasi has been at the Tufts Center for the Study of Drug Development since 1987. The Center is an independent non-profit multidisciplinary research organization affiliated with Tufts University. Prior to joining the Tufts Center, Dr. DiMasi was a member of the Department of Economics at the College of the Holy Cross. He received his Ph.D. in Economics from Boston College in 1984. Dr. DiMasi has served on the editorial boards of several research journals, has published in a variety of economic, medical, and scientific journals, and has presented his research at numerous professional and industry conferences. He testified before the U.S. Congress in hearings leading up to enactment of the Food and Drug Administration Modernization Act of 1997.
Dr. Isabelle Morize is a Lead Generation to Candidate Realization (LGCR) business coordinator at Sanofi-Aventis. She has 24 years experience working in the Molecular Modeling and Structural Biology field as scientist and manager in both France and the US. Dr. Morize received her doctorate in Physics at the University of Paris VII.
The Fine Print
ACS Webinars™ does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.